Homepage
Open in app
Sign in
Get started
ZS
Impact where it matters.
Follow
AI partnerships in medtech: A cause for cautious optimism
AI partnerships in medtech: A cause for cautious optimism
Learn about the promise and challenges about AI partnerships in medtech.
Bhargav Mantha
Apr 25
Pushing the generics button on the biosimilars contracting
Pushing the generics button on the biosimilars contracting
Unpacking alliances between biosimilar manufacturers and payers: A deep dive by ZS’s Biosimilars CoE
Prateek Yadav
Apr 13
Early-stage funding opportunities in Singapore: An interview with Guy Heathers Albatroz…
Early-stage funding opportunities in Singapore: An interview with Guy Heathers Albatroz…
The first step is the hardest: In the dynamic world of biotechnology, the journey begins with securing early-stage funding.
Mei Chee Lim
Apr 12
Advancing clear vision: Collaborating to address the escalating myopia epidemic
Advancing clear vision: Collaborating to address the escalating myopia epidemic
Our journey to treat myopia and prevent blindness must begin now.
Ashley John
Apr 9
Navigating uncertainty: The role of AI in addressing commercial challenges during a new drug launch
Navigating uncertainty: The role of AI in addressing commercial challenges during a new drug launch
In the world of pharmaceuticals, the launch phase is a pivotal stage where anticipation intertwines with uncertainty.
Debajyoti Das
Apr 8
The future of clinical development: Opportunities for disruption
The future of clinical development: Opportunities for disruption
With an increasing focus on improving efficiency and acceleration of clinical trials, we review opportunities for disruption.
Sowmyanarayan Srinivasan
Apr 8
ZS APAC Gen AI Summit: Exploring the power of Gen AI
ZS APAC Gen AI Summit: Exploring the power of Gen AI
Learn about how AI is reshaping industries and revolutionizing the way we live and work.
Manvi Kapoor
Apr 5
Access ahead: Powering the path in Europe’s private vaccine market
Access ahead: Powering the path in Europe’s private vaccine market
Understanding the dynamics of private payer engagement is imperative as vaccines target a broader range of diseases and populations.
Jennifer Wong
Apr 1
ACNU: Portfolio assessment, prioritization and scenario planning
ACNU: Portfolio assessment, prioritization and scenario planning
A new FDA rule, Additional Conditions for Non-Prescription Use (ACNU) will change the way Americans get their medications.
Dan Frey
Mar 20
AI pathology transforming the possibilities in precision medicine
AI pathology transforming the possibilities in precision medicine
At the Precision Medicine World Conference (PMWC), ZS gathered perspective on AI Pathology
Pavan Anné
Mar 18
Breaking barriers: Evolving role of the private sector in vaccine accessibility
Breaking barriers: Evolving role of the private sector in vaccine accessibility
Explore the impact of vaccines in public health and the shift towards private market expansion.
Adi Natu
Mar 15
TrailblazerDX: Innovation, investment and integrity
TrailblazerDX: Innovation, investment and integrity
Salesforce hosted TrailblazerDX, an annual conference designed for developers, architects, partners, engineers and…
Eric Ryan
Mar 14
The CDS Platform Landscape
The CDS Platform Landscape
How different companies are shaping access to the patient data, clinical systems, and physician workflows required to deliver CDS.
Richard Secker Johnson
Mar 14
The Big Game: Crafting a consumer-relevant commercial
The Big Game: Crafting a consumer-relevant commercial
Each year some of the biggest brands in the world look to The Big Game as a venue to engage a wide audience, read our assessment.
Bailey Winston
Mar 1
About ZS Associates
Latest Stories
Archive
About Medium
Terms
Privacy
Teams